Non-canonical NOTCH3 signalling limits tumour angiogenesis

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Notch signalling is a key driver of cancer, with targeted therapies focusing on the canonical pathway.
• The role of Notch3 in tumour angiogenesis and its interaction with ligands like Jagged-1 is not fully understood.

Purpose of the Study:

• To investigate the non-canonical role of Notch3 in regulating tumour angiogenesis.
• To elucidate the mechanism by which Jagged-1 influences Notch3-mediated endothelial cell apoptosis.
• To assess the therapeutic implications of targeting Notch3 in cancer.

Main Methods:

• Utilized Notch3 mutant mice to study tumour growth and angiogenesis.
• Investigated the interaction between Notch3 and its ligand Jagged-1 in cancer models.
• Analyzed the effect of γ-secretase inhibition on tumour vasculature and endothelial cell apoptosis.

Main Results:

• Notch3 exhibits a pro-apoptotic role in tumour vasculature, independent of the canonical Notch pathway.
• Cancer-derived Jagged-1 inhibits Notch3-induced endothelial cell death, promoting tumour growth and angiogenesis.
• Tumour growth and angiogenesis are increased in Notch3-silenced mice.
• The anti-tumour effects of γ-secretase inhibitors are partly mediated by Notch3-induced endothelial cell apoptosis.

Conclusions:

• Notch3 acts as a dependence receptor, inducing endothelial cell death, a process inhibited by Jagged-1.
• Targeting the Notch3-Jagged-1 interaction presents a novel therapeutic strategy for cancer.
• Understanding this non-canonical Notch3 function is crucial for developing effective cancer therapies.